Immunoglobulin G1, Anti-(Humanized Mouse Monoclonal Hr3 .Beta.1 Chain Anti-Human Epidermal Growth Factor Receptor), Disulfide With Humanized Mouse Monoclonal Hr3 .Kappa.-Chain, Dimer
Malignant Pancreatic Neoplasm
Chinese PLA General Hospitalmonoclonal_antibodyPhase 4 / ApprovedActive
BBB
76/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 63/ 100
- Competitive Position
- 95/ 100
Competitive context
314 Active assets in the Malignant Pancreatic Neoplasm cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Metformin State University of New York - Downstate Medical Center | Phase 2 | BBB |
Fluorouracilum Jonsson Comprehensive Cancer Center | Phase 4 | BBB |
Xaliplatin Jonsson Comprehensive Cancer Center | Phase 4 | BB |
Irinotecan Jonsson Comprehensive Cancer Center | Phase 3 | BB |
Cis-Diamminedichloroplatinum Ii Jonsson Comprehensive Cancer Center | Phase 2/3 | BB |
View all 50 →
Same molecule, other indications
Immunoglobulin G1, Anti-(Humanized Mouse Monoclonal Hr3 .Beta.1 Chain Anti-Human Epidermal Growth Factor Receptor), Disulfide With Humanized Mouse Monoclonal Hr3 .Kappa.-Chain, Dimer is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →